GMI

Quercetin and its derivatives have phosphodiesterase inhibitory activity equal to or superior to the drug AWD12-281 currently undergoing clinical trials for treating asthma and COPD.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *